After the Myriad decision: do hurdles remain for diagnostics competition?

After the Myriad decision: do hurdles remain for diagnostics competition?

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:MLO. Medical laboratory observer 2013-09, Vol.45 (9), p.46-46
Hauptverfasser: Waller, Patrick R H, Young, Daniel W
Format: Magazinearticle
Sprache:eng
Schlagworte:
Biotechnology industries
Biotechnology industry
Company legal issue
Complementary DNA
DNA - isolation & purification
Economic Competition
Genes, BRCA1
Genes, BRCA2
Genetic Testing - economics
Genetic Testing - legislation & jurisprudence
Health administration
Intellectual property
Medical societies
Patent/copyright issue
Patents as Topic - legislation & jurisprudence
Supreme Court Decisions
United States
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:
ISSN:0580-7247
2771-6759